HOME >> BIOLOGY >> NEWS
UCF nanoparticle offers promise for treating glaucoma

A unique nanoparticle made in a laboratory at the University of Central Florida is proving promising as a drug delivery device for treating glaucoma, an eye disease that can cause blindness and affects millions of people worldwide.

The nanoparticle can safely get past the blood-brain barrier making it an effective non-toxic tool for drug delivery, said Sudipta Seal, an engineering professor with appointments in UCFs Advanced Materials Processing and Analysis Center and the Nanoscience Technology Center.

The findings will be published in an article appearing in the June 28 issue of the Journal of Physical Chemistry C.

Seal and his colleagues from North Dakota State University note in the article that while barely 1-3 percent of existing glaucoma medicines penetrate into the eye, earlier experiments with nanoparticles have shown not only high penetration rates but also little patient discomfort. The miniscule size of the nanoparticles makes them less abrasive than some of the complex polymers now used in most eye drops.

Seal and his team created a specialized cerium oxide nanoparticle and bound it with a compound that has been shown to block the activity of an enzyme (hCAII) believed to play a central role in causing glaucoma.

The disease involves abnormally high pressure of the fluid inside the eye, which, if left untreated, can result in damage to the optic nerve and vision loss. High pressure occurs, in part, because of a buildup of carbon dioxide inside the eye, and the compound blocks the enzyme that produces carbon dioxide.

Seal and a team of collaborators including Sanku Mallik, of North Dakota State University, developed the research on using nanoparticles as a delivery mechanism for the compound after supervising a student summer project at UCF. Duke University undergraduate Serge Reshetnikov spent a summer studying nanoscience on UCFs Orlando campus as part of a Research Experience for Underg
'"/>

Contact: Zenaida Gonzalez Kotala
zkotala@mail.ucf.edu
407-823-6120
University of Central Florida
18-Jun-2007


Page: 1 2

Related biology news :

1. Gold nanoparticles may pan out as tool for cancer diagnosis
2. Under magnetic force, nanoparticles may deliver gene therapy
3. UCSB researchers show how to make polymeric micro- and nanoparticles
4. Pairing nanoparticles with proteins
5. In nature, proteins sweep up nanoparticles
6. Bacteria ferry nanoparticles into cells for early diagnosis, treatment
7. MU researchers examine the environmental effects of silver nanoparticles
8. Work with nanoparticles may lead to on-the-spot virus detector
9. Widely used iron nanoparticles exhibit toxic effects on neuronal cells
10. Test finds manufactured nanoparticles dont harm soil ecology
11. DNA nanoparticles hold promise in gene therapy for Parkinsons disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2018)... FRANCISCO (PRWEB) , ... August ... ... provider of advanced software solutions for biopharma R&D, today announced that Seattle-based ... their preferred bioinformatics solution provider. Aptevo will use the Genedata Biologics ...
(Date:8/17/2018)... N.J. and LIEGE, Belgium (PRWEB) , ... ... ... Diagenode today announced the acquisition of NXT-Dx, an established epigenetics service provider ... services including a number of targeted DNA methylation assays using pyrosequencing or ...
(Date:8/17/2018)... ROCK, Colo. (PRWEB) , ... August 16, 2018 , ... ... facioscapulohumeral muscular dystrophy (FSHD), announced that its Colorado Chapter will be holding its ... scheduled for September 8th at the Philip S. Miller Park, advocates for public awareness ...
Breaking Biology News(10 mins):
(Date:9/12/2018)... (PRWEB) , ... September 11, 2018 , ... ... at the American Association of Feline Practitioners Conference (AAFP) later this ... data on adipose-derived stem cell therapy for the treatment of chronic kidney disease ...
(Date:9/7/2018)... ... 06, 2018 , ... The Discovery on Target (DOT) conference ... industry’s preeminent event on novel drug targets.” BellBrook Labs’ high throughput screening (HTS) ... emerging targets in a quest to find new treatments for disease. , BellBrook ...
(Date:9/1/2018)... ... 2018 , ... Rudina Thanasi, a scientifically validated holistic energy ... treated nutraceutical supplement used in combating inflammation and autoimmune disorders. , ... as, organ-specific inflammation. The reported data is as follows: , More than ...
(Date:8/29/2018)... , ... August 28, 2018 , ... Cognition Corporation ... full lineup of talks for NAVIGATE2018 . , Ryan Ward, Director of ... Cognition’s annual user conference. An experienced engineer and manager with Zimmer Biomet for almost ...
Breaking Biology Technology:
Cached News: